Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amedisys

97.89
+0.38000.39%
Post-market: 97.890.00000.00%16:33 EDT
Volume:410.52K
Turnover:40.13M
Market Cap:3.21B
PE:36.05
High:97.95
Open:97.36
Low:97.36
Close:97.51
Loading ...

Chordia Therapeutics Awarded 30 Million Yen AMED Grant for Cancer Therapy Research

MT Newswires Live
·
Yesterday

Press Release: Rakuten Medical's Anti-PD-L1 Antibody-IR700 Conjugate, RM-0256, Selected for AMED Funding

Dow Jones
·
05 Jun

Amedisys: Hold Rating Amid Mixed Financial Signals and Uncertainty Post-Merger Announcement

TIPRANKS
·
25 Apr

Analysts Conflicted on These Healthcare Names: Amedisys (AMED), Siemens Healthineers AG (OtherSEMHF) and Penumbra (PEN)

TIPRANKS
·
24 Apr

William Blair Sticks to Its Hold Rating for Amedisys (AMED)

TIPRANKS
·
24 Apr

Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics

Zacks
·
24 Apr

Amedisys Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
24 Apr

Amedisys: Q1 Earnings Snapshot

Associated Press Finance
·
24 Apr

Amedisys Extends Credit Facility Amid Merger Talks

TIPRANKS
·
24 Apr

Amedisys reports Q1 adjusted EPS $1.25, consensus $1.11

TIPRANKS
·
24 Apr

Amedisys Q1 Adj. EPS $1.25 Beats $1.09 Estimate, Sales $594.78M Miss $596.22M Estimate

Benzinga
·
24 Apr

BRIEF-Amedisys Q1 Net Income USD 61 Million

Reuters
·
24 Apr

Amedisys Reports First Quarter 2025 Financial Results

GlobeNewswire
·
24 Apr

Top Research Reports for Visa, ServiceNow & Progressive

Zacks
·
22 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
21 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
18 Apr

Amedisys Price Target Maintained With a $100.00/Share by RBC Capital

Dow Jones
·
16 Apr

Amedisys (AMED) Earnings Expected to Grow: Should You Buy?

Zacks
·
16 Apr

RBC Capital Remains a Buy on Amedisys (AMED)

TIPRANKS
·
16 Apr

Here's Why You Should Retain AMED Stock in Your Portfolio Now

Zacks
·
19 Mar